Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71


Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?

Facciabene A, Santoro S, Coukos G.

Oncoimmunology. 2012 Jul 1;1(4):575-577.


Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer.

Ren L, Yu Y, Wang L, Zhu Z, Lu R, Yao Z.

Oncotarget. 2016 Nov 15;7(46):75763-75773. doi: 10.18632/oncotarget.12409.


Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G.

Nature. 2011 Jul 13;475(7355):226-30. doi: 10.1038/nature10169.


Regulatory T cells and innate immune regulation in tumor immunity.

Wang RF.

Springer Semin Immunopathol. 2006 Aug;28(1):17-23. Epub 2006 Jul 13. Review. Erratum in: Springer Semin Immunopathol. 2006 Aug;28(1):77.


CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M.

Cancer Res. 2012 Sep 1;72(17):4351-60. doi: 10.1158/0008-5472.CAN-12-0579. Epub 2012 Jul 12.


Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.

Yuan XL, Chen L, Li MX, Dong P, Xue J, Wang J, Zhang TT, Wang XA, Zhang FM, Ge HL, Shen LS, Xu D.

Clin Immunol. 2010 Mar;134(3):277-88. doi: 10.1016/j.clim.2009.10.005. Epub 2009 Nov 8.


Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.

Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, Wang H, Chen J, Wang H.

PLoS One. 2011 Apr 29;6(4):e19495. doi: 10.1371/journal.pone.0019495.


Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells.

Svensson H, Olofsson V, Lundin S, Yakkala C, Björck S, Börjesson L, Gustavsson B, Quiding-Järbrink M.

PLoS One. 2012;7(2):e30695. doi: 10.1371/journal.pone.0030695. Epub 2012 Feb 1.


CD103 is a hallmark of tumor-infiltrating regulatory T cells.

Anz D, Mueller W, Golic M, Kunz WG, Rapp M, Koelzer VH, Ellermeier J, Ellwart JW, Schnurr M, Bourquin C, Endres S.

Int J Cancer. 2011 Nov 15;129(10):2417-26. doi: 10.1002/ijc.25902. Epub 2011 Apr 1.


Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage?

Cannon MJ, Goyne H, Stone PJ, Chiriva-Internati M.

Expert Opin Biol Ther. 2011 Apr;11(4):441-5. doi: 10.1517/14712598.2011.554812. Epub 2011 Jan 28. Review.


Quantification of tumor infiltrating Foxp3+ regulatory T cells enables the identification of high-risk patients for developing synchronous cancers over upper aerodigestive tract.

Wang WL, Chang WL, Yang HB, Chang IW, Lee CT, Chang CY, Lin JT, Sheu BS.

Oral Oncol. 2015 Jul;51(7):698-703. doi: 10.1016/j.oraloncology.2015.04.015. Epub 2015 May 7.


Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.

Strauss L, Bergmann C, Szczepanski MJ, Lang S, Kirkwood JM, Whiteside TL.

J Immunol. 2008 Mar 1;180(5):2967-80.


Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.

Akeus P, Langenes V, Kristensen J, von Mentzer A, Sparwasser T, Raghavan S, Quiding-Järbrink M.

Eur J Immunol. 2015 Jun;45(6):1654-66. doi: 10.1002/eji.201445058. Epub 2015 Apr 14.


What are regulatory T cells (Treg) regulating in cancer and why?

Whiteside TL.

Semin Cancer Biol. 2012 Aug;22(4):327-34. doi: 10.1016/j.semcancer.2012.03.004. Epub 2012 Mar 28. Review.


Regulatory T cells control macrophage accumulation and activation in lymphoma.

Galani IE, Wendel M, Stojanovic A, Jesiak M, Müller MM, Schellack C, Suri-Payer E, Cerwenka A.

Int J Cancer. 2010 Sep 1;127(5):1131-40. doi: 10.1002/ijc.25132.


Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.

Conrad C, Gregorio J, Wang YH, Ito T, Meller S, Hanabuchi S, Anderson S, Atkinson N, Ramirez PT, Liu YJ, Freedman R, Gilliet M.

Cancer Res. 2012 Oct 15;72(20):5240-9. doi: 10.1158/0008-5472.CAN-12-2271. Epub 2012 Jul 31.


Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.

Fialová A, Partlová S, Sojka L, Hromádková H, Brtnický T, Fučíková J, Kocián P, Rob L, Bartůňková J, Spíšek R.

Int J Cancer. 2013 Mar 1;132(5):1070-9. doi: 10.1002/ijc.27759. Epub 2012 Aug 24.


Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.

Han Y, Yang Y, Chen Z, Jiang Z, Gu Y, Liu Y, Xu S, Lin C, Pan Z, Zhou W, Cao X.

J Mol Med (Berl). 2014 May;92(5):539-50. doi: 10.1007/s00109-014-1143-4. Epub 2014 Mar 26.


Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.

Kimpfler S, Sevko A, Ring S, Falk C, Osen W, Frank K, Kato M, Mahnke K, Schadendorf D, Umansky V.

J Immunol. 2009 Nov 15;183(10):6330-7. doi: 10.4049/jimmunol.0900609. Epub 2009 Oct 19.


Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.

Crane CA, Ahn BJ, Han SJ, Parsa AT.

Neuro Oncol. 2012 May;14(5):584-95. doi: 10.1093/neuonc/nos014. Epub 2012 Mar 9.

Supplemental Content

Support Center